Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GNMSF - Genmab down 20% on Darzalex setback


GNMSF - Genmab down 20% on Darzalex setback

  • Genmab A/S (OTCPK:GNMSF -20%) slumps on the news that collaboration partner Johnson & Johnson (JNJ -1.2%) has scrapped an early-stage study assessing the combination of DARZALEX (daratumumab) + Roche's TECENTRIQ (atezolizumab) in second-line lung cancer due to lack of efficacy and a safety signal, specifically an imbalance of deaths compared to placebo.
  • More news on: Genmab A/S, Johnson & Johnson, Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Genmab A/S Dkk
Stock Symbol: GNMSF
Market: OTC
Website: genmab.com

Menu

GNMSF GNMSF Quote GNMSF Short GNMSF News GNMSF Articles GNMSF Message Board
Get GNMSF Alerts

News, Short Squeeze, Breakout and More Instantly...